Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2016-05-11

FDA Approved: OXALIPLATIN — Original Application (Qilu Pharmaceutical Co., Ltd.)

View source ↗

Summary

FDA approved Qilu Pharmaceutical Co., Ltd.'s generic oxaliplatin under Original Application (ANDA204616), providing a generic option for colorectal cancer indic…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • OXALIPLATIN (Oxaliplatin)

Snippet

ORIG AP for OXALIPLATIN (OXALIPLATIN)